The Coxib case: Are EP receptors really guilty?

Santilli, Francesca; Boccatonda, Andrea; Davì, Giovanni; Cipollone, Francesco

Santilli, Francesca; Boccatonda, Andrea; Davì, Giovanni; Cipollone, Francesco.

Affiliation

Santilli F; Department of Internal Medicine, "G. d'Annunzio" University, Chieti, Italy.
Boccatonda A; Department of Internal Medicine, "G. d'Annunzio" University, Chieti, Italy.
Davì G; Department of Internal Medicine, "G. d'Annunzio" University, Chieti, Italy.
Cipollone F; Department of Internal Medicine, "G. d'Annunzio" University, Chieti, Italy. Electronic address: fcipollone@unich.it.

Atherosclerosis ; 249: 164-73, 2016 06.

Article in En | MEDLINE | ID: mdl-27105159

Subject(s)

Anti-Inflammatory Agents, Non-Steroidal/therapeutic use; Cyclooxygenase 2 Inhibitors/chemistry; Cyclooxygenase 2/metabolism; Animals; Anticoagulants/therapeutic use; Blood Platelets/metabolism; Dinoprostone/metabolism; Humans; Hypertension/drug therapy; Kidney/drug effects; Kidney/metabolism; Mice; Myocardium/metabolism; Prostaglandin-Endoperoxide Synthases/metabolism; Receptors, Prostaglandin/metabolism; Risk Factors

Key words

Coxib; EP receptor; NSAIDs; Platelet; Prostaglandin

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Anti-Inflammatory Agents, Non-Steroidal / Cyclooxygenase 2 / Cyclooxygenase 2 Inhibitors Type of study: Etiology_studies Limits: Animals / Humans Language: En Journal: Atherosclerosis Year: 2016 Document type: Article Affiliation country: Italy Country of publication: Ireland

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google